16
Participants
Start Date
February 20, 2017
Primary Completion Date
January 21, 2022
Study Completion Date
January 21, 2022
Adult Allogeneic Mesenchymal cells from adipose tissue.
"Study treatment consists of Mesenchymal Stem Cell (MSC) derived from donors adipose tissue and expanded in vitro in a specific medium with platelet lysate without addition of animal derived products.~Subjects will receive four sequential IV dose of Mesenchymal stem cells.~Sequential doses:~Day 1: 0.7-1 x 106 MSC / kg Day 4: 0.7-1 x 106 MSC / kg Day 11: 0.7-1 x 106 MSC / kg Day 18: 0.7-1 x 106 MSC / kg"
Hospital Clínico Universitario Virgen de la Arrixaca, Murcia
Clinica Universitaria de Navarra, Av Pio XII ,36, Pamplona
Hospital clinico universitario de salamanca, Salamanca
Virgen del Rocio University Hospital, av. Manuel Siurot s/n, Seville
Hospital Universitario Reina Sofía, Córdoba
Hospital Regional Universitario de Málaga, Málaga
Andalusian Initiative for Advanced Therapies
OTHER_GOV
Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud
OTHER